Production (Stage)
ARS Pharmaceuticals, Inc.
SPRY
$14.98
$0.463.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.20% | 53.32% | -6.37% | -2.19% | -2.07% |
| Total Receivables | 12.14% | 639.47% | 128.60% | -12.30% | -9.91% |
| Inventory | 39.49% | 628.95% | -- | -- | -- |
| Prepaid Expenses | 106.26% | 262.06% | 34.97% | -17.17% | -43.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -21.83% | 68.77% | 46.88% | -40.69% | 28.53% |
| Total Current Assets | -9.10% | 60.11% | -5.41% | -2.43% | -2.37% |
|
|
|||||
| Total Current Assets | -9.10% | 60.11% | -5.41% | -2.43% | -2.37% |
| Net Property, Plant & Equipment | 7.60% | 14.01% | 19.57% | -3.93% | -1.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.51% | -2.44% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 82.79% | -- | -- | -15.53% | 2,414.29% |
| Total Assets | -6.79% | 61.37% | -1.97% | -2.47% | -2.40% |
|
|
|||||
| Total Accounts Payable | -41.10% | 70.67% | 152.93% | 289.99% | 10.54% |
| Total Accrued Expenses | 149.08% | -41.11% | 129.52% | 25.57% | 584.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 73.81% | -58.82% | -36.25% | -26.27% | -8.44% |
| Total Finance Division Other Current Liabilities | 73.60% | 326.73% | 436.16% | 4.19% | -79.29% |
| Total Other Current Liabilities | 73.60% | 326.73% | 436.16% | 4.19% | -79.29% |
| Total Current Liabilities | 17.84% | 41.01% | 147.18% | 81.02% | 55.37% |
|
|
|||||
| Total Current Liabilities | 17.84% | 41.01% | 147.18% | 81.02% | 55.37% |
| Long-Term Debt | 0.00% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.60% | -- | -- | -- | -- |
| Total Liabilities | 4.23% | 467.62% | 147.18% | 81.02% | 53.01% |
|
|
|||||
| Common Stock & APIC | 1.65% | 1.61% | 1.19% | 1.07% | 0.99% |
| Retained Earnings | -27.53% | 28.82% | -12.41% | -8.84% | -7.84% |
| Treasury Stock & Other | -67.27% | -35.10% | 333.79% | -16.94% | -353.06% |
| Total Common Equity | -10.83% | 27.77% | -6.63% | -3.85% | -2.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.83% | 27.77% | -6.63% | -3.85% | -2.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.83% | 27.77% | -6.63% | -3.85% | -2.99% |
|
|
|||||